Hallal David
- SEC CIK
- 0001457477
In the past year, 2 open-market sale filings worth $3.97M and no purchases.
Current role at each company
- SRRK Scholar Rock Holding CorpChief Executive Officeras of Sep 23, 2026
- KLRS Kalaris Therapeutics, Inc.Directoras of Jun 4, 2026
- ITOS iTeos Therapeutics, Inc.Directoras of Aug 29, 2025
- SEER Seer, Inc.Directoras of Jun 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.97M
- 2 filings
- Net
- −$3.97M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hallal David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRRK Scholar Rock Holding Corp
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Hallal DavidChief Executive Officer | SSale | −30.6K | $49.57 | −$1.52M | −1.8%1.64M after | |
| Jan 15, 2026 (view filing) | Jan 13 | 2 days | Hallal DavidChief Executive Officer | SSale | −57.5K | $42.70 | −$2.45M | −3.6%1.54M after |
ITOS iTeos Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 (view filing) | Jun 4-6 | 2 days | Hallal DavidDirector | SSale | −114.7K | $10.15 | −$1.16M | −100.0%0 after | 3 lots10b5-1 |
| Jun 10, 2022 (view filing) | Jun 8-9 | 2 days | Hallal DavidDirector | SSale | −29.6K | $20.17 | −$597.2K | −100.0%0 after | 4 lots |
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Hallal DavidDirector | SSale | −50.0K | $43.57 | −$2.18M | −100.0%0 after |
KLRS Kalaris Therapeutics, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2022 (view filing) | Oct 19 | 2 days | Hallal DavidDirector, 10% Owner | SSale | −600.0K | $8.45 | −$5.07M | −81.3%138.2K after | |
| Sep 30, 2022 (view filing) | Sep 29 | 1 day | Hallal DavidDirector, 10% Owner | SSale | −400.0K | $7.35 | −$2.94M | −35.7%721.0K after | |
| Jul 21, 2022 (view filing) | Jul 21 | Same day | Hallal DavidDirector, 10% Owner | SSale | −4.23K | $5.33 | −$22.5K | −0.2%2.07M after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Hallal DavidDirector, 10% Owner | SSale | −65.7K | $3.67 | −$241.2K | −3.1%2.08M after | |
| Apr 22, 2022 (view filing) | Apr 21 | 1 day | Hallal DavidDirector, 10% Owner | SSale | −4.23K | $5.87 | −$24.8K | −0.2%2.14M after | |
| Mar 11, 2022 (view filing) | Mar 10-11 | 1 day | Hallal DavidDirector, 10% Owner | SSale | −65.7K | $7.48 | −$491.7K | −3.0%2.15M after | 2 lots |
| Jan 25, 2022 (view filing) | Jan 24 | 1 day | Hallal DavidDirector, 10% Owner | SSale | −17.1K | $8.01 | −$137.0K | −0.8%2.21M after |